Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 8/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | HPGD | P15428 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | STAT3 | P40763 | 1/20 | 0.51 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | CASP7 | P55210 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2054396 | 0.95 | TLR8 (0.55) | TLR8ALDH1A1HPGDKDM4EGAA | |
| SCHEMBL133672 | 0.94 | TLR8 (0.54) | TLR8ALDH1A1HPGDKDM4EGAA | |
| SCHEMBL17179261 | 0.82 | ALDH1A1 (0.58) | TLR8ALDH1A1HPGDKDM4EGAA | |
| SCHEMBL28162401 | 0.81 | TLR8 (0.69) | TLR8ALDH1A1HPGDPDE10AGLA | |
| SCHEMBL27524779 | 0.80 | TLR8 (0.62) | TLR8ALDH1A1HPGDKDM4EGAA | |
| SCHEMBL28146814 | 0.80 | TLR8 (0.62) | TLR8ALDH1A1HPGDPDE10AGLA | |
| SCHEMBL28214718 | 0.80 | TLR8 (0.62) | TLR8ALDH1A1HPGDPDE10AGLA | |
| SCHEMBL19841045 | 0.78 | TLR8 (0.49) | TLR8ALDH1A1HPGDKDM4ETRPV1 | |
| SCHEMBL1122100 | 0.77 | RXFP1 (0.49) | MAPT | |
| SCHEMBL16862729 | 0.77 | RXFP1 (0.49) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2601221-A1 | STABILIZER | BASF SE (DE) | 2013-06-12 | — | — | EP | disclosed |
| US-20120071563-A1 | STABILIZER | BASF SE (DE) | 2012-03-22 | — | — | US | disclosed |
| WO-2012017012-A1 | STABILIZER | BASF SE (DE) | 2012-02-09 | — | — | WO | disclosed |
| EP-1583547-B1 | ANTI-OBESITY INGREDIENTS FROM MEDICINAL PLANTS AND THEIR COMPOSITION | KOREA INST ORIENTAL MEDICINE (KR) | 2009-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071563-A1 | STABILIZER | MGAM, AMY1A, MGAM2 | TLR8 2873/4885ALDH1A1 1947/4885HPGD 3750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.